Page results
-
King Charles III and Queen Camilla met patients and families living with cancer to hear their hopes and fears as they received care at UCLH in London today.
-
UCLH has recruited the first participant for a new UK based study for Parkinson’s Disease (PD). The ASPro-PD study is testing whether treatment with a drug called ambroxol is associated with an improvement in motor and non-motor function compared with placebo.
-
UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.
-
Read more about the NHS Staff Survey 2024 - we’re the top acute trust to work at for third year running!
-
Holistic Needs Assessment (HNA): Information for people affected by cancer and blood conditions patient information leaflet
-
Our staff have rated UCLH as the top trust in London to work at, and the third best in the country, during what has been another incredibly challenging year.
-
Researchers at UCLH have begun a study which could set the foundations for how booster COVID-19 vaccinations are delivered in the future.
-
Read more about a UCLH patient saved by special 'before midnight' transfusions.
-
This page explains the Rafaelo™ procedure, a treatment for haemorrhoids, which are also known as piles.
-
UCLH has declared a climate and health emergency and has published an action plan to reach net zero carbon dioxide emissions.
File results
-
FOI/2024/0318 - Patients absconded from medium/ high-security psychiatric facilities
-
FOI/2024/0320 - Treatment for rare diseases; fabry, gaucher and pompe diseases
-
FOI/2024/0326 - Treatment of Haemophilia B and Von Willebrand disease
-
FOI/2024/0327 - Treatment of non-UK nationals
-
FOI/2024/0329 - Metastatic renal cell carcinoma patients/ classification
-
FOI/2024/0464 - Theatre sessions/ productivity
-
FOI/2024/0467 - Drug Patient Level Contract Monitoring (DrPLCM) and SACT Cancer reports
-
FOI/2024/0333 - Elective treatment wait over 65 weeks
-
FOI/2024/0337 - IVF clinical unit/ embryology laboratory
-
FOI/2024/0338 - Ophthalmology outpatient activity 2022, 2023 and 2024